Description
CDP-771, CMA-676 (ADC), WAY-CMA-676, gemtuzumab ozogamicin, CAS: 220578-59-6
Targets
Myeloid cell surface antigen CD33, Sialic acid-binding Ig-like lectin 3, Siglec-3, CD33, gp67, SIGLEC3
Isotype/Mimetic
IgG4-kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression